BRPI0919034A8 - Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso - Google Patents
Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vasoInfo
- Publication number
- BRPI0919034A8 BRPI0919034A8 BRPI0919034A BRPI0919034A BRPI0919034A8 BR PI0919034 A8 BRPI0919034 A8 BR PI0919034A8 BR PI0919034 A BRPI0919034 A BR PI0919034A BR PI0919034 A BRPI0919034 A BR PI0919034A BR PI0919034 A8 BRPI0919034 A8 BR PI0919034A8
- Authority
- BR
- Brazil
- Prior art keywords
- methods
- antibody
- protein
- vessel
- producing
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 3
- 108090000623 proteins and genes Proteins 0.000 title abstract 3
- 239000007788 liquid Substances 0.000 title abstract 2
- 239000006143 cell culture medium Substances 0.000 abstract 1
- 239000002609 medium Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2863—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0043—Medium free of human- or animal-derived components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0056—Xeno-free medium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/76—Undefined extracts from plants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Abstract
MÉTODOS PARA PRODUZIR UMA PROTEÍNA E UM ANTICORPO, MEIO LÍQUIDO AQUOSO PARA CULTURA, E, VASO. A presente invenção fornece, em parte, métodos para expressar recombinantemente proteínas em um nível alto junto com meios de cultura de células para realizar o mesmo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10045008P | 2008-09-26 | 2008-09-26 | |
PCT/US2009/058164 WO2010036767A1 (en) | 2008-09-26 | 2009-09-24 | High titer antibody production |
Publications (2)
Publication Number | Publication Date |
---|---|
BRPI0919034A2 BRPI0919034A2 (pt) | 2015-08-18 |
BRPI0919034A8 true BRPI0919034A8 (pt) | 2016-02-10 |
Family
ID=41334376
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0919034A BRPI0919034A8 (pt) | 2008-09-26 | 2009-09-24 | Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110229933A1 (pt) |
EP (1) | EP2342318A1 (pt) |
JP (1) | JP2012503487A (pt) |
KR (1) | KR20110060911A (pt) |
CN (1) | CN102224239A (pt) |
AU (1) | AU2009296708A1 (pt) |
BR (1) | BRPI0919034A8 (pt) |
CA (1) | CA2737580A1 (pt) |
CO (1) | CO6351809A2 (pt) |
IL (1) | IL211639A0 (pt) |
MX (1) | MX2011003241A (pt) |
NZ (1) | NZ591651A (pt) |
RU (1) | RU2011116319A (pt) |
WO (1) | WO2010036767A1 (pt) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PE20090368A1 (es) | 2007-06-19 | 2009-04-28 | Boehringer Ingelheim Int | Anticuerpos anti-igf |
MX2011006055A (es) | 2008-12-12 | 2011-07-04 | Boehringer Ingelheim Int | Anticuerpos anti-igf. |
CA2797140C (en) * | 2010-04-26 | 2018-01-23 | Novartis Ag | Improved cell culture medium |
KR101591671B1 (ko) | 2011-04-29 | 2016-02-04 | 바이오콘 리서치 리미티드 | 항체의 이질성을 감소시키는 방법 및 그 항체의 제조방법 |
CA2841822C (en) | 2011-07-12 | 2016-08-16 | Foodchek Systems Inc. | Culture medium, method for culturing salmonella and e. coli and method for detecting salmonella and e. coli |
US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
WO2014054744A1 (ja) * | 2012-10-03 | 2014-04-10 | 協和発酵キリン株式会社 | 培養液にアミノ酸を添加することによるポリペプチドの還元防止方法 |
US20140255413A1 (en) | 2013-03-07 | 2014-09-11 | Boehringer Ingelheim International Gmbh | Combination therapy for neoplasia treatment |
US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
AR095196A1 (es) * | 2013-03-15 | 2015-09-30 | Regeneron Pharma | Medio de cultivo celular libre de suero |
WO2014145098A1 (en) * | 2013-03-15 | 2014-09-18 | Genentech, Inc. | Cell culture compositions with antioxidants and methods for polypeptide production |
ITTO20130493A1 (it) * | 2013-06-14 | 2014-12-15 | Determinants Of Metabolism Res Lab S R L | Composizione per l'eliminazione di animali molesti infestanti |
CN104212769B (zh) * | 2014-07-14 | 2017-05-10 | 北京益生合生物科技有限公司 | 一种用于高产单抗的细胞培养基添加剂 |
US20180105555A1 (en) * | 2015-03-20 | 2018-04-19 | Bristol-Myers Squibb Company | Use of dextran for protein purification |
CA3208857A1 (en) * | 2015-04-01 | 2016-10-06 | Boehringer Ingelheim International Gmbh | Cell culture medium |
GB201506870D0 (en) | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
GB201506869D0 (en) * | 2015-04-22 | 2015-06-03 | Ucb Biopharma Sprl | Method |
WO2016190394A1 (ja) | 2015-05-27 | 2016-12-01 | アステラス製薬株式会社 | 核酸含有培地を用いた細胞培養方法 |
TWI797060B (zh) | 2015-08-04 | 2023-04-01 | 美商再生元醫藥公司 | 補充牛磺酸之細胞培養基及用法 |
HU231463B1 (hu) * | 2015-08-04 | 2024-01-28 | Richter Gedeon Nyrt. | Módszer rekombináns proteinek galaktóz tartalmának növelésére |
CN107460221B (zh) * | 2016-06-02 | 2021-01-15 | 正大天晴药业集团股份有限公司 | 一种降低抗pd-l1抗体中蛋白聚合物的细胞培养方法 |
WO2018018613A1 (zh) * | 2016-07-29 | 2018-02-01 | 广东东阳光药业有限公司 | 一种提高抗体纯度的细胞培养基和培养方法 |
CN106479982A (zh) * | 2016-10-17 | 2017-03-08 | 深圳万乐药业有限公司 | 抗pd‑1单克隆抗体生产用细胞培养基及其优化方法 |
JP2018113907A (ja) * | 2017-01-18 | 2018-07-26 | 株式会社Regene Pharm | 動物細胞の培養方法 |
WO2018224673A1 (en) | 2017-06-08 | 2018-12-13 | Zaklady Farmaceutyczne Polpharma S.A. | Improved methods of cell culture |
CA3068685A1 (en) * | 2017-06-27 | 2019-01-03 | Ajinomoto Co., Inc. | Riboflavin derivative-containing medium |
BR112021025769A2 (pt) | 2019-12-06 | 2022-04-12 | Regeneron Pharma | Composições de proteína anti-vegf e métodos para a produção das mesmas |
CN113117455B (zh) * | 2021-04-12 | 2022-11-22 | 江西师范大学 | 氯化胆碱-甘油低共熔溶剂在吸收HCl气体中的应用 |
CN115369069B (zh) * | 2022-08-22 | 2023-12-19 | 上海健士拜生物科技有限公司 | 293细胞补料培养基及其制备和应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT409379B (de) * | 1999-06-02 | 2002-07-25 | Baxter Ag | Medium zur protein- und serumfreien kultivierung von zellen |
AU784506B2 (en) * | 1999-08-25 | 2006-04-13 | Immunex Corporation | Compositions and methods for improved cell culture |
WO2003100008A2 (en) * | 2002-05-24 | 2003-12-04 | Schering Corporation | Neutralizing human anti-igfr antibody |
-
2009
- 2009-09-24 CN CN2009801468374A patent/CN102224239A/zh active Pending
- 2009-09-24 JP JP2011529210A patent/JP2012503487A/ja not_active Withdrawn
- 2009-09-24 NZ NZ59165109A patent/NZ591651A/xx not_active IP Right Cessation
- 2009-09-24 RU RU2011116319/10A patent/RU2011116319A/ru not_active Application Discontinuation
- 2009-09-24 CA CA 2737580 patent/CA2737580A1/en not_active Abandoned
- 2009-09-24 MX MX2011003241A patent/MX2011003241A/es active IP Right Grant
- 2009-09-24 US US13/120,558 patent/US20110229933A1/en not_active Abandoned
- 2009-09-24 EP EP09792931A patent/EP2342318A1/en not_active Withdrawn
- 2009-09-24 BR BRPI0919034A patent/BRPI0919034A8/pt not_active IP Right Cessation
- 2009-09-24 WO PCT/US2009/058164 patent/WO2010036767A1/en active Application Filing
- 2009-09-24 AU AU2009296708A patent/AU2009296708A1/en not_active Abandoned
- 2009-09-24 KR KR20117006874A patent/KR20110060911A/ko not_active Application Discontinuation
-
2011
- 2011-03-08 IL IL211639A patent/IL211639A0/en unknown
- 2011-03-28 CO CO11037693A patent/CO6351809A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
CA2737580A1 (en) | 2010-04-01 |
NZ591651A (en) | 2012-12-21 |
US20110229933A1 (en) | 2011-09-22 |
AU2009296708A1 (en) | 2010-04-01 |
EP2342318A1 (en) | 2011-07-13 |
RU2011116319A (ru) | 2012-11-10 |
MX2011003241A (es) | 2011-04-21 |
BRPI0919034A2 (pt) | 2015-08-18 |
WO2010036767A1 (en) | 2010-04-01 |
JP2012503487A (ja) | 2012-02-09 |
CO6351809A2 (es) | 2011-12-20 |
KR20110060911A (ko) | 2011-06-08 |
IL211639A0 (en) | 2011-05-31 |
CN102224239A (zh) | 2011-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0919034A8 (pt) | Métodos para produzir uma proteína e um anticorpo, meio líquido aquoso para cultura, e, vaso | |
CR20120371A (es) | Antagonistas de pcsk9 | |
MX2022008013A (es) | Estabilizacion de polipeptidos que contienen fragmentos cristalizables. | |
BRPI0911038A2 (pt) | métodos para expressar uma sequência heteróloga em uma célula hospedeira e para produzir um isoprenóide em uma célula hospedeira, célula hospedeira, vetor de expressão, conjunto de vetores de expressão, kit, e, cultura celular. | |
BRPI0916964A2 (pt) | polipetídeo, anticorpo, ácido nucléico, vetor, célula hospedeira, método para produzir um polipeptídeo, composição e uso do polipeptídeo | |
BRPI0914855A2 (pt) | dispositivo de controle para dispositivo de exibição de cristal líquido, dispositivo de exibição de cristal líquido, método para controle de dispositivo de exibição de cristal líquido, programa e meio de armazenameto. | |
BRPI0618449A2 (pt) | métodos para produção de isoformas de receptor e ligante | |
MX353382B (es) | Moleculas de union polipeptido de larga duracion. | |
EP2808393A3 (en) | Fucosylation-deficient cells | |
BR112012026379A2 (pt) | métodos para gerar proteína endogenamente marcada | |
BRPI0816094A2 (pt) | Anticorpo, polipeptídeo, hibridoma, composição farmacêutica, método para inibir o desenvolvimento de tumor em um mamífero, polinucleotídeo, célula hospedeira, e, método para produzir um anticorpo. | |
CL2013002361A1 (es) | Metodo para medir actividad de células natural killer (nk); kit para medir dicha actividad; proteína de fusión; composicion para activar células nk; polipéptido, oligonucleótido, vector y célula hospedera que comprenden la proteína; | |
BR112012004856A2 (pt) | aparelho de acesso condicional, aparelho fonte, método para gerar seletivamente um sinal com um aparelho de acesso condicional, e, meio de armazenamento legível por computador. | |
BR112014006405A2 (pt) | anticorpo, conjunto, e, método para medir um complexo de afinidade | |
CL2011003278A1 (es) | Método para replegar una proteína expresada en un sistema de expresión no mamífero y presente en un volumen a una concentración de 2 g/l o mayor, que comprende poner en contacto la proteína con una solución amortiguadora al menos 2 mm que comprende un componente de óxidoreducción, desnaturalizante, antiagregante y estabilizador. | |
WO2008034622A3 (en) | A method of detecting and/or quantifying expression of a target protein candidate in a cell, and a method of identifying a target protein of a small molecule modulator | |
EP2530290A4 (en) | Method for determining fuel quality, program, computer readable recording medium having the program stored thereupon, and device for determining fuel quality | |
WO2007130543A3 (en) | Method for producing stable mammalian cell lines producing high levels of recombinant proteins | |
BR112016021739A2 (pt) | Método para preparar um poloxâmero para uso em um meio de cultura de célula | |
AU2018276376A1 (en) | Cell culture methods | |
WO2008090290A3 (fr) | Milieu de culture synthétique chimiquement défini | |
BRPI0920987A2 (pt) | método para reproduzir conteúdo, aparelho para reproduzir conteúdo, e meio de gravação legível por computador. | |
WO2011145126A3 (en) | A method for the preparation of conjugates based on transglutaminase | |
WO2008096570A1 (ja) | マイクロチップ、およびマイクロチップ検査システム | |
WO2009125999A3 (en) | Human host cell for producing recombinant proteins with high quality and quantity |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A E 6A ANUIDADES. |
|
B25D | Requested change of name of applicant approved |
Owner name: MERCK SHARP AND DOHME CORP. (US) |
|
B25G | Requested change of headquarter approved |
Owner name: MERCK SHARP AND DOHME CORP. (US) |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |